Investor mix
9 investors on record; lead investors include Sands Capital Ventures, NeoMed, Borealis Ventures; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 78% |
| Private equity | 1 | 11% |
| Accelerator & incubator | 1 | 11% |
Affinity purification solutions provider for biopharmaceutical manufacturing, improving purity, yield, efficiency
9 investors on record; lead investors include Sands Capital Ventures, NeoMed, Borealis Ventures; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 78% |
| Private equity | 1 | 11% |
| Accelerator & incubator | 1 | 11% |